Clinical Trials | December 30, 2025
One jab, six months: Leuprolide mesylate shows strong efficacy in children with precocious puberty
The study met its primary endpoint with flying colors
The study met its primary endpoint with flying colors
Xeureka will receive an upfront payment from UBE and will be eligible for milestone payments tied to future research progress
Speakers for the Session are: Venkata Prasad K., Unit Head, Deepak Nitrite; Abhilash Pasham, Associate General Manager - Central Engineering & Projects, Dr. Reddy's Laboratories; C. V. Rajulu, Consultant, Industry; and Jyoti Shankar Jha, Senior Lead Scientist, Alleima India. The moderator for the Session is Pravin Prashant, Executive Editor, Indian Pharma Post
Neuberg group commits to invest over Rs. 100 crores to start diagnostics facilities across Jharkhand in the next 2-3 years
European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
For over 13 years, Star Imaging has pioneered the introduction of next-generation radiology technologies in Pune
Women Health Card was launched exclusively for women health workers of the Tiruchirappalli City Corporation
FlexiTubes will showcase range of eco-friendly and innovative tube options
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria
Subscribe To Our Newsletter & Stay Updated
